Separation of the ADC Brentuximab vedotin from its aggregates and fragments
contributed by YMC |
Drug-to-antibody ratios (DAR) of antibody-drug-conjugates (ADCs) are important for their therapeutic efficacy and pharmacokinetics. Typically, the DAR of 2nd generation ADC such as Brentuximab vedotin (Adcetris®) is determined by hydrophobic interaction chromatography (HIC).
Read the full article now
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!
